Maze Therapeutics is an operator of a biotechnology firm used to focus on translating genetic insights into new medicines.

Maze Therapeutics is a biotechnology firm used to focus on translating genetic insights into new medicines. The company's translating genetic insights into new medicines by utilizing an approach that combines the analysis of large-scale human genetics data, functional genomics, and an array of drug discovery approaches. and it also reveals modifier genes that confer protection and provide a deeper understanding of the target biology and how these targets can be targeted with drug therapies, enabling patients with protection against diseases.

Maze Therapeutics

Associate Director, Clinical Science

Bolt Biotherapeutics is a biotechnology company that develops a platform for cancer immunotherapy.

Bolt Biotherapeutics is a biotechnology company that develops a platform for cancer immunotherapy. Its platform, Boltbody, is a cancer immunotherapy that consists of immune-stimulating antibody conjugates.

Bolt Biotherapeutics

Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.

Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages. The company understands that advances in cancer research now enable drug developers to identify children and adults who may benefit from the same medicine. They develop new therapies that meet the critical needs of people of all ages living with cancer starting from the biology of childhood cancer. Day One Biopharmaceuticals also focuses its efforts to bring the best medicines to families receiving the life-altering news of a new cancer diagnosis and the need for a treatment plan.  It prioritizes programs that can be rapidly brought to market for both younger and older patients. The company's goal is to license and acquire the most promising products from research institutions as well as for biotechnology and pharmaceutical companies. Day One Biopharmaceuticals was founded in 2018 and is headquartered in South San Francisco, CA, USA.

Day One Biopharmaceuticals

Associate Director, Clinical Science Trainer

boltbio

Equillium is a biotechnology company that develops products for autoimmune and inflammatory disorders with an unmet medical need.

Equillium Inc is a biotechnology company that develops products for autoimmune and inflammatory, or immuno-inflammatory disorders with an unmet medical need. Its primary product candidate is EQ001, which is a clinical-stage first-in-class monoclonal antibody that selectively targets the novel immune checkpoint receptor CD6. CD6 plays a central role in effector T cell activity, which drives a number of immuno-inflammatory diseases such as graft versus host disease, asthma, uveitis, colitis, lupus, and multiple sclerosis.

Equillium

Kura Oncology, a biopharmaceutical company, advances a pipeline of precision medicines for the treatment of solid tumors and blood cancers.

At Kura Oncology, They are committed to realizing the promise of precision medicines for cancer. The genomics revolution is transforming how they treat cancer. They now understand that how a patient responds to treatment depends in part on the genetic makeup of the cancer and, importantly, we have the knowledge and tools to create targeted treatments and companion diagnostics to identify those patients most likely to benefit. This new era offers the potential for innovative treatments that are safer and more effective for patients with particular cancers. They are leveraging our insights into cancer genetics as well as our core strength of translating novel science into life-saving medicines to advance a pipeline of precision medicines. Their development programs target cancers with high unmet need, including lung, colorectal, thyroid and pancreatic cancers as well as blood cancers such as lymphoma and leukemias.

Kura Oncology

Associate Director, Clinical Scientist

Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.

Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.The company's therapies deliver nucleic acids and other molecules to skeletal, cardiac and smooth muscle with unprecedented precision, enabling patients to restore muscle strength and transform their lives.

Location

Company Stage

Age of Data

Experience

Industry

Company

Associate Director, Clinical Science

Maze Therapeutics

$200k - $245k

$200,000 - $245,000

Bolt Biotherapeutics

$175k - $205k

$175,000 - $205,000

Day One Biopharmaceuticals

$187k - $200k

$187,000 - $200,000

boltbio

$150k - $198k

$150,000 - $197,500

Equillium

$180k - $195k

$180,000 - $195,000

Kura Oncology

$165k - $195k

$165,000 - $195,000

Dyne Therapeutics

N/A

N/A